Reversal of CD8+ T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC

N. Dalyot-Herman, O. F. Bathe, Thomas Malek

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

In the present report, we have studied the potential of naive and activated effector CD8+ T cells to function as anti-tumor T cells to a solid tumor using OVA-specific T cells from TCR-transgenic OT-I mice. Adoptive transfer of naive OT-I T cells into tumor-bearing syngeneic mice did not inhibit tumor cell growth. The adoptively transferred OT-I T cells did not proliferate in lymphoid tissue of tumor-bearing mice and were not anergized by the tumor. In contrast, adoptive transfer of preactivated OT-I CTL inhibited tumor growth in a dose-dependent manner, indicating that E.G7 was susceptible to immune effector cells. Importantly, naive OT-I T cells proliferated and elicited an anti-tumor response if they were adoptively transferred into normal or CD4-deficient mice that were then vaccinated with GM-CSF-induced bone marrow-derived OVA-pulsed APC. Collectively, these data indicate that even though naive tumor-specific T cells are present at a relatively high fraction they remain ignorant of the tumor and demonstrate that a CD8-mediated anti-tumor response can be induced by Ag-pulsed APC without CD4 T cell help.

Original languageEnglish
Pages (from-to)6731-6737
Number of pages7
JournalJournal of Immunology
Volume165
Issue number12
StatePublished - Dec 15 2000

Fingerprint

Immunity
T-Lymphocytes
Peptides
Neoplasms
Adoptive Transfer
Lymphoid Tissue
Granulocyte-Macrophage Colony-Stimulating Factor
Growth
Bone Marrow

ASJC Scopus subject areas

  • Immunology

Cite this

Reversal of CD8+ T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC. / Dalyot-Herman, N.; Bathe, O. F.; Malek, Thomas.

In: Journal of Immunology, Vol. 165, No. 12, 15.12.2000, p. 6731-6737.

Research output: Contribution to journalArticle

@article{44d70faa8d9a495aacbfab7e94317e99,
title = "Reversal of CD8+ T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC",
abstract = "In the present report, we have studied the potential of naive and activated effector CD8+ T cells to function as anti-tumor T cells to a solid tumor using OVA-specific T cells from TCR-transgenic OT-I mice. Adoptive transfer of naive OT-I T cells into tumor-bearing syngeneic mice did not inhibit tumor cell growth. The adoptively transferred OT-I T cells did not proliferate in lymphoid tissue of tumor-bearing mice and were not anergized by the tumor. In contrast, adoptive transfer of preactivated OT-I CTL inhibited tumor growth in a dose-dependent manner, indicating that E.G7 was susceptible to immune effector cells. Importantly, naive OT-I T cells proliferated and elicited an anti-tumor response if they were adoptively transferred into normal or CD4-deficient mice that were then vaccinated with GM-CSF-induced bone marrow-derived OVA-pulsed APC. Collectively, these data indicate that even though naive tumor-specific T cells are present at a relatively high fraction they remain ignorant of the tumor and demonstrate that a CD8-mediated anti-tumor response can be induced by Ag-pulsed APC without CD4 T cell help.",
author = "N. Dalyot-Herman and Bathe, {O. F.} and Thomas Malek",
year = "2000",
month = "12",
day = "15",
language = "English",
volume = "165",
pages = "6731--6737",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - Reversal of CD8+ T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC

AU - Dalyot-Herman, N.

AU - Bathe, O. F.

AU - Malek, Thomas

PY - 2000/12/15

Y1 - 2000/12/15

N2 - In the present report, we have studied the potential of naive and activated effector CD8+ T cells to function as anti-tumor T cells to a solid tumor using OVA-specific T cells from TCR-transgenic OT-I mice. Adoptive transfer of naive OT-I T cells into tumor-bearing syngeneic mice did not inhibit tumor cell growth. The adoptively transferred OT-I T cells did not proliferate in lymphoid tissue of tumor-bearing mice and were not anergized by the tumor. In contrast, adoptive transfer of preactivated OT-I CTL inhibited tumor growth in a dose-dependent manner, indicating that E.G7 was susceptible to immune effector cells. Importantly, naive OT-I T cells proliferated and elicited an anti-tumor response if they were adoptively transferred into normal or CD4-deficient mice that were then vaccinated with GM-CSF-induced bone marrow-derived OVA-pulsed APC. Collectively, these data indicate that even though naive tumor-specific T cells are present at a relatively high fraction they remain ignorant of the tumor and demonstrate that a CD8-mediated anti-tumor response can be induced by Ag-pulsed APC without CD4 T cell help.

AB - In the present report, we have studied the potential of naive and activated effector CD8+ T cells to function as anti-tumor T cells to a solid tumor using OVA-specific T cells from TCR-transgenic OT-I mice. Adoptive transfer of naive OT-I T cells into tumor-bearing syngeneic mice did not inhibit tumor cell growth. The adoptively transferred OT-I T cells did not proliferate in lymphoid tissue of tumor-bearing mice and were not anergized by the tumor. In contrast, adoptive transfer of preactivated OT-I CTL inhibited tumor growth in a dose-dependent manner, indicating that E.G7 was susceptible to immune effector cells. Importantly, naive OT-I T cells proliferated and elicited an anti-tumor response if they were adoptively transferred into normal or CD4-deficient mice that were then vaccinated with GM-CSF-induced bone marrow-derived OVA-pulsed APC. Collectively, these data indicate that even though naive tumor-specific T cells are present at a relatively high fraction they remain ignorant of the tumor and demonstrate that a CD8-mediated anti-tumor response can be induced by Ag-pulsed APC without CD4 T cell help.

UR - http://www.scopus.com/inward/record.url?scp=0034671810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034671810&partnerID=8YFLogxK

M3 - Article

C2 - 11120791

AN - SCOPUS:0034671810

VL - 165

SP - 6731

EP - 6737

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -